
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Journey through Pages: A Survey of \Plunging into Scholarly Universes\ - 2
Anthony Joshua's driver charged over Nigeria crash that killed two - 3
Home Remodel Administrations: Change Your Residing Space - 4
Cheetah, Hammerhead Shark, and 38 Other Animals in Danger of Extinction Receive New International Protections from U.N. - 5
France honors the victims of the Paris attacks' night of terror 10 years on
25 of the world’s best sandwiches
How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'
When is MLK Day? Plus, the dates of when other federal holidays land in 2026.
Why ordering takeout or calling the dog walker might lead to a happier relationship
the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
What you need to know about desalination, a growing source of drinking water
She just became the first wheelchair user to travel to space
Instructions to Pick the Right Senior Protection Plan.
Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer













